1
|
Anvari D, Rezaei F, Ashouri A, Rezaei S, Majidiani H, Pagheh AS, Rezaei F, Shariatzadeh SA, Fotovati A, Siyadatpanah A, Gholami S, Ahmadpour E. Current situation and future prospects of Echinococcus granulosus vaccine candidates: A systematic review. Transbound Emerg Dis 2020; 68:1080-1096. [PMID: 32762075 DOI: 10.1111/tbed.13772] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 07/20/2020] [Accepted: 08/01/2020] [Indexed: 12/14/2022]
Abstract
Cystic echinococcosis is a worldwide zoonotic disease, represents a threat for livestock and humans, manifests as a quiescent, subclinical and chronic hydatid cyst infection. The disease imposes high expenditures and economic losses in medical and veterinary. Prophylactic vaccination would be one of the effective preventive health care against echinococcosis. During the last decades, many studies have characterized the protective antigens of Echinococcus granulosus and their role in immunization of various animal host species. Herein, we aimed to systematically evaluate and represent the best antigens as possible vaccine candidates for cystic echinococcosis. Data were systematically searched from five databases including ProQuest, PubMed, Scopus, ScienceDirect and Web of Science, up to 1 February 2020. Two reviewers independently screened and assessed data extraction and quality assessment. A total of 47 articles were eligible for inclusion criteria in the current study. The most common antigens used for vaccination against E. granulosus were EG95 and antigen B. Freund's adjuvant and Quil A have been predominantly utilized. In addition, regarding the antigen delivery, animal models, measurement of immune responses and reduction in hydatid cyst have been discussed in the text. The data demonstrated that DNA vaccines with antigen B and recombinant protein vaccines based on EG95 antigen have the best results and elicited protective immune responses.
Collapse
Affiliation(s)
- Davood Anvari
- Student Research Committee, Mazandaran University of Medical Science, Sari, Iran.,Department of Parasitology, School of Medicine, Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.,School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran
| | - Fatemeh Rezaei
- Faculty of Modern Sciences and Technologies, Islamic Azad University of Medical Sciences, Tehran, Iran
| | - Alireza Ashouri
- Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
| | - Saeed Rezaei
- Faculty of Veterinary Medicine, Islamic Azad University, Karaj, Iran
| | - Hamidreza Majidiani
- Zonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran
| | - Abdol Sattar Pagheh
- Infectious Disease Research Center, Birjand University of Medical Sciences, Birjand, Iran
| | - Fatemeh Rezaei
- Department of Parasitology, School of Medicine, Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran
| | - Seyyed Ali Shariatzadeh
- Student Research Committee, Mazandaran University of Medical Science, Sari, Iran.,Department of Parasitology, School of Medicine, Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran
| | - Amir Fotovati
- Faculty of Veterinary Medicine, University of Zabol, Zabol, Iran
| | | | - Shirzad Gholami
- Department of Parasitology, School of Medicine, Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran
| | - Ehsan Ahmadpour
- Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.,Department of Parasitology and Mycology, Tabriz University of Medical Sciences, Tabriz, Iran
| |
Collapse
|
2
|
Yin D, Li L, Song D, Liu Y, Ju W, Song X, Wang J, Pang B, Xu K, Li J. A novel recombinant multi-epitope protein against Brucella melitensis infection. Immunol Lett 2016; 175:1-7. [DOI: 10.1016/j.imlet.2016.04.016] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2016] [Revised: 04/16/2016] [Accepted: 04/26/2016] [Indexed: 01/22/2023]
|
3
|
Li Y, Zhang F, Althunayan MH, Hu XA, Xin Y, Jia H, Guo Y, Ma X, Wen H, Ding J. Construction and identification of the recombinant plasmid pET30a-EgA31-Eg95 of Echinococcus granulosus.. Exp Ther Med 2013; 7:204-208. [PMID: 24348791 PMCID: PMC3861358 DOI: 10.3892/etm.2013.1393] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2013] [Accepted: 09/27/2013] [Indexed: 11/16/2022] Open
Abstract
To clone the Eg95 and EgA31 antigen genes into the prokaryotic expression plasmid pET30a-EgA31-Eg95, we expressed the recombinant protein EgA31-Eg95 and confirmed with western blot analysis. The total RNA was extracted from the protoscoleces of Echinococcus granulosus (E. granulosus) adult worms. The complementary DNA (cDNA) encoding the EgA31 antigen was amplified via quantitative real-time polymerase chain reaction (qPCR). The recombinant plasmid pET30a-EgA31 was used as a carrier and was connected with the Eg95 vector. The recombinant plasmid pET30a-EgA31-Eg95 was constructed and the fusion protein EgA31-Eg95 was detected using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The positive clone was the empty recombinant vector. The recombinant protein pET30a-EgA31-Eg95 was ~46 kDa, and the expressed product accounted for approximately 20% of the total soluble proteins. We successfully constructed the recombinant plasmid pET30a-EgA31-Eg95 and expressed the recombinant protein EgA31-Eg95. The results may be the foundation of research on its immunogenicity in the future.
Collapse
Affiliation(s)
- Yanhua Li
- Xinjiang Laboratory of Hydatid Fundamental Medicine, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Fengbo Zhang
- Xinjiang Laboratory of Hydatid Fundamental Medicine, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Mohammed H Althunayan
- Xinjiang Laboratory of Hydatid Fundamental Medicine, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Xiao-An Hu
- Department of Immunology, College of Basic Medicine of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Yan Xin
- Department of Immunology, College of Basic Medicine of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Haiying Jia
- Department of Immunology, College of Basic Medicine of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Yuyuan Guo
- Department of Immunology, College of Basic Medicine of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Xiumin Ma
- Xinjiang Laboratory of Hydatid Fundamental Medicine, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Hao Wen
- Xinjiang Laboratory of Hydatid Fundamental Medicine, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| | - Jianbing Ding
- Xinjiang Laboratory of Hydatid Fundamental Medicine, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China ; Department of Immunology, College of Basic Medicine of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
| |
Collapse
|